FOXO FOXO TECHNOLOGIES INC.
Services-Commercial Physical & Biological Research · OTC · SEC CIK 1812360 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
Margins
Returns
Leverage & solvency
Cash quality & payout
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $7.00M | $4.72M | $5.17M | $4.43M | $3.55M | $5.22M | $3.17M | $2.82M |
| R&D expense | $0 | $23,700 | $35,550 | $35,219 | $77,096 | $40,183 | $30,000 | $267 |
| SG&A expense | $3.00M | $2.68M | $2.88M | $3.50M | $2.47M | $2.62M | $2.76M | $3.03M |
| Operating income | $1.58M | $8.75M | -$276,851 | -$8.49M | -$859,821 | $567,121 | -$1.55M | -$3.99M |
| Interest expense | $1.35M | $1.31M | $973,135 | $601,239 | $934,223 | $1.01M | $889,792 | $2.11M |
| Pretax income | $96,281 | $8.14M | -$1.46M | -$9.60M | -$1.88M | -$526,306 | -$620,808 | -$6.80M |
| Net income | $101,301 | $8.14M | -$1.45M | -$9.42M | -$1.88M | -$522,021 | -$616,458 | -$6.79M |
| EBITDA | $1.75M | $8.92M | -$105,757 | -$8.33M | -$716,618 | $569,378 | -$1.40M | -$3.55M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| Balance sheet | ||||||||
| Cash & equivalents | $42,678 | $58,409 | $65,896 | $207,453 | $628,557 | $321,789 | $16,907 | $68,268 |
| Receivables | $3.47M | $4.14M | $3.91M | $2.47M | $3.16M | $4.92M | $2.65M | $2.27M |
| Inventory | $161,033 | $160,469 | $188,565 | $183,627 | $7,747 | — | — | $161,466 |
| Current assets | $4.05M | $4.76M | $4.49M | $3.11M | $4.17M | $5.63M | $3.19M | $2.88M |
| PP&E, net | $265,019 | $286,865 | $303,544 | $322,357 | $326,624 | $307,202 | $328,030 | $364,481 |
| Goodwill | $26.53M | $27.79M | $27.79M | $27.82M | $34.83M | $31.30M | $30.60M | $25.46M |
| Intangibles | $9.61M | $9.76M | $9.78M | $9.77M | $9.10M | $9.01M | $9.01M | $9.02M |
| Total assets | $43.60M | $45.89M | $45.79M | $44.58M | $52.09M | $50.02M | $47.01M | $41.71M |
| Current liabilities | $39.82M | $40.62M | $31.56M | $28.66M | $28.64M | $32.90M | $33.79M | $31.20M |
| Total liabilities | $43.60M | $44.98M | $36.15M | $33.50M | $31.96M | $36.34M | $37.36M | $36.44M |
| Shareholders' equity | $86,337 | $988,306 | $9.71M | $11.14M | $20.20M | $13.74M | $9.71M | $5.32M |
| Cash flow statement | ||||||||
| Operating cash flow | $395,042 | $298,674 | -$577,898 | -$104,030 | -$44,784 | -$2.38M | -$1.34M | -$1.85M |
| Capital expenditure | $0 | $5,379 | $3,995 | $18,741 | $28,380 | — | — | — |
| Free cash flow | $395,042 | $293,295 | -$581,893 | -$122,771 | -$73,164 | — | — | — |
| Investing cash flow | $0 | -$5,379 | -$3,995 | -$18,741 | -$621,965 | — | — | -$671 |
| Financing cash flow | -$410,773 | -$300,782 | $440,336 | -$298,333 | $973,517 | $2.70M | $1.29M | $1.88M |
| Depreciation & amortization | $169,162 | $175,793 | $171,094 | $164,412 | $143,203 | $2,257 | $143,044 | $438,585 |
| Stock-based compensation | $0 | -$9.10M | — | $1 | -$210,804 | $18,878 | $27,716 | -$194,565 |
Free plan shows the latest 8 periods; Pro shows all 24 🔒
· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.